Bayer EBITDA 2012-2025 | BAYRY

Bayer EBITDA for the quarter ending December 31, 2025 was $-2.761B, a 176.96% decline year-over-year.

  • Bayer 2025 EBITDA was 1.932B, a 79.5% decline from 2024.
  • Bayer 2024 EBITDA was 9.427B, a 18.07% decline from 2023.
  • Bayer 2023 EBITDA was 11.507B, a 19.19% decline from 2022.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Bayer EBITDA 2012-2025 | BAYRY

  • Bayer 2025 EBITDA was 1.932B, a 79.5% decline from 2024.
  • Bayer 2024 EBITDA was 9.427B, a 18.07% decline from 2023.
  • Bayer 2023 EBITDA was 11.507B, a 19.19% decline from 2022.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Innoviva (INVA)$1.8B